You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Article info

Article menu

Download PDFPDF

XML
Research Article
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Authors

  • Christina A. Hartl Department of Cancer Immunology and VirologyDana-Farber Cancer Institute 02215 Boston MA USA Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women’s CancersDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Adrian Bertschi Department of Cancer Immunology and VirologyDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Regina Bou Puerto Department of Cancer Immunology and VirologyDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Carolin Andresen Department of Cancer Immunology and VirologyDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Emily M. Cheney Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women’s CancersDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Elizabeth A. Mittendorf Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women’s CancersDana-Farber Cancer Institute 02215 Boston MA USA Division of Breast Surgery, Department of SurgeryBrigham and Women’s Hospital 02215 Boston MA USA Breast Oncology Program, Dana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Jennifer L. Guerriero Breast Tumor Immunology Laboratory, Susan F. Smith Center for Women’s CancersDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  • Michael S. Goldberg Department of Cancer Immunology and VirologyDana-Farber Cancer Institute 02215 Boston MA USA PubMed articlesGoogle scholar articles
  1. ↵g jennifer_guerriero{at}dfci.harvard.edu
  2. ↵h michael_goldberg1{at}dfci.harvard.edu
View Full Text

Citation

Hartl CA, Bertschi A, Puerto RB, et al
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer
Journal for ImmunoTherapy of Cancer 2019;7:199. doi: 10.1186/s40425-019-0654-5

Publication history

  • Received February 6, 2019
  • Accepted June 27, 2019
  • First published July 30, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.